Table 2.
Reported Service Integration, August 2012 (n = 23)
| Health service setting | Number of organizations offering services
|
||
|---|---|---|---|
| Only on-site | Only referral | Total (on-site + referral)a | |
| Substance abuse and mental health settings (n = 20) | |||
| Screening, diagnosis, and counseling for infectious diseases | |||
| Routine HIV testing | 15 (75%) | 5 (25%) | 20 (100%) |
| Routine TB screening | 8 (40%) | 10 (50%) | 18 (90%) |
| Syphilis screening at intake | 8 (40%) | 7 (35%) | 15 (75%) |
| HCV testing | 4 (20%) | 9 (45%) | 13 (65%) |
| GC/CT screening at intake | 4 (20%) | 8 (40%) | 12 (60%) |
| Vaccination | |||
| Vaccination for HAV and HBV | 3 (15%) | 12 (60%) | 15 (75%) |
| Interventions for reduction of risk behaviors | |||
| Overdose prevention education | 13 (65%) | 1 (5%) | 14 (70%) |
| Access to condoms | 8 (40%) | 3 (15%) | 11 (55%) |
| Access to drug preparation equipment | 1 (5%) | 3 (15%) | 4 (20%) |
| Referrals and linkage to care | |||
| HIV patients referred to care and progress tracked | 8 (40%) | 11 (55%) | 19 (95%) |
| Referral to behavioral interventions | 8 (40%) | 10 (50%) | 18 (90%) |
| HIV clinical settings (n = 3) | |||
| Screening, diagnosis, and counseling for infectious diseases | |||
| Persons newly diagnosed HIV+ persons screened for syphilis, GC/CT | 3 (100%) | 0 (0%) | 3 (100%) |
| Persons newly diagnosed with HIV screened for TB | 2 (67%) | 1 (33%) | 3 (100%) |
| HCV testing for all patients | 2 (67%) | 1 (33%) | 3 (100%) |
| Vaccination | |||
| HBV vaccination for all patients | 2 (67%) | 1 (33%) | 3 (100%) |
| Interventions for reduction of risk behaviors | |||
| Overdose prevention education | 2 (67%) | 0 (0%) | 2 (67%) |
| Access to condoms | 1 (33%) | 0 (0%) | 1 (33%) |
| Access to drug prep equipment | 0 (0%) | 1 (33%) | 1 (33%) |
| Referrals and linkage to care | |||
| Referral to behavioral interventions | 2 (67%) | 1 (33%) | 3 (100%) |
| Partner Services and contact follow-up | |||
| Partner services | 1 (33%) | 0 (0%) | 1 (33%) |
| Risk assessment for infectious diseases | |||
| Ongoing, routine risk assessment and annual screening for syphilis, GC/CT | 3 (100%) | 0 (0%) | 3 (100%) |
| Risk assessment for illicit use of drugs | |||
| Risk assessment for reproductive health, substance abuse and mental disorders | 3 (100%) | 0 (0%) | 3 (100%) |
Two advocacy groups were excluded because they provided education but no direct services. The health department, which provided a wide array of services, chose to be assessed as a substance abuse treatment setting, although they are not a substance abuse organization per their primary mission. Organizations that provided services for both substance abuse and HIV equally were asked to choose to answer either the substance abuse or HIV services checklist questions, indicated in the rows above, and were classified according to their choice
HIV Human Immunodeficiency Virus, TB tuberculosis, HAV hepatitis A, HBV hepatitis B, HCV hepatitis C, GC/CT Gonorrhea/Chlamydia, SC syphilis
On-site service provision received priority in coding. Providers were first asked whether their organization provided services on-site; if they responded no, they were asked whether they offered the services through referral